ITIL vs FDA 21 CFR Part 11
ITIL
Best-practices framework for IT service management
FDA 21 CFR Part 11
FDA regulation for trustworthy electronic records and signatures
Quick Verdict
ITIL provides voluntary ITSM best practices for global IT organizations to align services with business goals, while FDA 21 CFR Part 11 mandates controls for electronic records and signatures in US life sciences to ensure data trustworthiness and regulatory compliance.
ITIL
ITIL 4 IT Service Management Framework
Key Features
- Service Value System (SVS) for value co-creation
- 34 flexible practices across three categories
- Seven guiding principles for decision-making
- Four dimensions balancing service management aspects
- Continual improvement embedded throughout framework
FDA 21 CFR Part 11
21 CFR Part 11 Electronic Records; Electronic Signatures
Key Features
- Secure computer-generated time-stamped audit trails
- Risk-based system validation for accuracy
- Unique multi-component electronic signatures
- Closed and open system controls
- Access limitation and authority checks
Detailed Analysis
A comprehensive look at the specific requirements, scope, and impact of each standard.
ITIL Details
What It Is
ITIL 4, a standalone best-practices framework for IT Service Management (ITSM), originated from UK government efforts in the 1980s. Its primary purpose is aligning IT services with business objectives across the full lifecycle, emphasizing value co-creation through the Service Value System (SVS) and flexible, agile approaches.
Key Components
- SVS elements: 7 guiding principles, governance, Service Value Chain (6 activities), 34 practices (14 general, 17 service, 3 technical), continual improvement.
- **Four dimensionsorganizations/people, information/technology, partners/suppliers, value streams/processes.
- Built on real-world practices; certifications from Foundation to Strategic Leader via PeopleCert.
Why Organizations Use It
Drives cost efficiencies, 87% global adoption, reduced downtime (e.g., 20% faster resolutions), risk mitigation amid $3M+ breaches. Enables DevOps/Agile integration, builds common language, boosts customer satisfaction, careers, and reputation.
Implementation Overview
Phased 10-step roadmap: assessment, gap analysis, tailoring, training, tool integration (e.g., CMDB). Suited for enterprises/SMEs globally; voluntary, customizable to avoid rigidity.
FDA 21 CFR Part 11 Details
What It Is
FDA 21 CFR Part 11 is a U.S. regulation defining criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies a risk-based approach to controls ensuring authenticity, integrity, and confidentiality in FDA-regulated activities, primarily for records under predicate rules.
Key Components
- **Subpart BControls for closed (§11.10) and open (§11.30) systems, including validation, audit trails, access limits, operational/authority/device checks.
- **Subpart CElectronic signatures with uniqueness (§11.100), manifestation (§11.50), linking (§11.70), multi-component controls (§11.200/300).
- Core principles: ALCOA+ data integrity; no formal certification, but FDA enforcement and inspections.
Why Organizations Use It
- Mandatory for life sciences using electronic records in GxP (pharma, devices, biotech).
- Mitigates enforcement risks (warnings, holds); enhances data integrity, inspection readiness.
- Drives efficiency, paperless operations, stakeholder trust.
Implementation Overview
- Phased: scoping, risk assessment, CSV (IQ/OQ/PQ), SOPs, training, vendor governance.
- Targets regulated industries; U.S.-focused; ongoing audits, no external certification.
Key Differences
| Aspect | ITIL | FDA 21 CFR Part 11 |
|---|---|---|
| Scope | ITSM best practices, service lifecycle | Electronic records/signatures trustworthiness |
| Industry | All IT organizations worldwide | US life sciences, pharma, devices |
| Nature | Voluntary best-practice framework | Mandatory US federal regulation |
| Testing | Certifications, continual improvement | System validation, IQ/OQ/PQ |
| Penalties | No legal penalties | Warning letters, fines, holds |
Scope
Industry
Nature
Testing
Penalties
Frequently Asked Questions
Common questions about ITIL and FDA 21 CFR Part 11
ITIL FAQ
FDA 21 CFR Part 11 FAQ
You Might also be Interested in These Articles...

How to Implement CIS Controls v8.1 as a ‘Control Backbone’ for NIS2 & DORA (Step-by-Step Implementation Guide)
Deploy CIS Controls v8.1 as a control backbone for NIS2 & DORA compliance. Step-by-step roadmap (IG1→IG2), deliverables, metrics & evidence model for hybrid/clo

From SOC to AI-Native CDC: Redefining Triage and Response in 2026
Explore the shift from SOCs to AI-Native CDCs. Autonomous agents handle Tier 1 triage in 2026, empowering analysts for complex threats. Discover the future of c

NIST 800-53 Private Sector ROI Uncovered: 2025 Podcast Deep Dive into Control Family Impact on $10M+ Breach Aversions
Uncover NIST 800-53 ROI in healthcare & finance: RA, SI, IR controls break even after 1-2 incidents ($100K-$10M savings). Podcast deep dive with CISO metrics fo
Run Maturity Assessments with GRADUM
Transform your compliance journey with our AI-powered assessment platform
Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.
Explore More Comparisons
See how ITIL and FDA 21 CFR Part 11 compare against other standards